The Wall Street Journal featured Erlanger Health System‘s emerging technology for innovative stroke treatment.

The business-focused newspaper published two May 14 articles, which showcase different parts of Erlanger’s work.

The lead article, “New Technology Promises to Speed Clinical Treatment for Stroke,” details a new technology called (the ai stands for artificial intelligence) that Erlanger neurology specialist Dr. Tom Devlin and his medical team helped develop and roll out to other hospitals, according to a news release.

That report is accompanied by a sidebar piece, “How Doctors Locate Stroke Victims’ Brain Clots,” which describes the inner workings of Erlanger’s emergency/trauma center and angiogram suite.


It also highlights the work of interventional radiology specialist Dr. Harris Hawk and Erlanger neurologist Dr. Emily Decroos.

The lead article described a computerized system that uses artificial intelligence to automatically interpret brain scans and recognize blocked arteries with the brains of stroke victims at referral hospitals.

This system then alerts the emergency room staff and Erlanger’s stroke team that the patient requires immediate transfer to a major stroke center like Erlanger for mechanical clot extraction from the brain.

With the system a stroke diagnosis can be made and all brain images automatically sent to phones of Erlanger’s stroke team for review within minutes.

The Wall Street Journal article also described another new technology developed by Devlin in partnership with a California biomedical engineering company, Neural Analytics.

Using data from Erlanger’s stroke patient population, Devlin and Neural Analytics developed a portable transcranial Doppler headgear that automatically identifies large vessel occlusions needing thrombectomy.

This device—called the LUCID system—can be used in ambulances, other pre-hospital settings, or anywhere in the hospital to rapidly diagnose a stroke caused by a large vessel occlusion, also according to a news release.

“By detecting in the ambulance which patients have blood flow disruption, this device has the potential to revolutionize stroke care,” Devlin told The Wall Street Journal.